Tenet Healthcare (THC) Tops Q1 EPS by 25c, Revenues Beat; Offers Q2 & FY19 Revenue Mid-Point Guidance Above Consensus, Provides 2Q/FY19 EPS Views

Go back to Tenet Healthcare (THC) Tops Q1 EPS by 25c, Revenues Beat; Offers Q2 & FY19 Revenue Mid-Point Guidance Above Consensus, Provides 2Q/FY19 EPS Views

Tenet Reports Results for the First Quarter Ended March 31, 2019

April 29, 2019 4:15 PM EDT

Tenet reported a net loss from continuing operations attributable to Tenet common shareholders of $27 million or $0.26 per diluted share in the first quarter of 2019 due in part to a $47 million pre-tax loss from the extinguishment of debt or $0.45 per diluted share. Adjusted diluted earnings per share from continuing operations were $0.54 in the first quarter of 2019, above the high end of the Companys Outlook. Adjusted EBITDA was $613 million in the first quarter of 2019, above the midpoint of the Companys Outlook. Adjusted EBITDA consisted of $337 million in the... More